The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Infanrix hexa

GlaxoSmithKline Biologicals S.A.EU/1/00/152/001

Main Information

Trade NameInfanrix hexa
Active SubstancesHaemophilus influenzae
Pertussis toxoid
Tetanus toxoid
Diphtheria toxoid
Hbs ag
Filamentous haemagglutinin (fha)
Dosage FormPowder and suspension for suspension for injection
Licence HolderGlaxoSmithKline Biologicals S.A.
Licence NumberEU/1/00/152/001

Group Information

ATC CodeJ07CA Bacterial and viral vaccines, combined
J07CA09 diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B


License statusAuthorised
Licence Issued23/10/2000
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back